Onconetix Inc. (NASDAQ: ONCO)
$0.15
-0.0004 ( -0.27% ) 729.7K
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
Market Data
Open
$0.15
Previous close
$0.15
Volume
729.7K
Market cap
$3.24M
Day range
$0.14 - $0.15
52 week range
$0.10 - $0.54
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 68 | Nov 17, 2023 |
nt | Quarterly Reports | 1 | Nov 15, 2023 |
8-k | 8K-related | 13 | Nov 02, 2023 |
8-k | 8K-related | 13 | Oct 30, 2023 |
10-q | Quarterly Reports | 72 | Oct 20, 2023 |
8-k | 8K-related | 12 | Oct 18, 2023 |
3 | Insider transactions | 1 | Oct 10, 2023 |
3 | Insider transactions | 1 | Oct 10, 2023 |
8-k | 8K-related | 17 | Oct 10, 2023 |
8-k | 8K-related | 14 | Oct 03, 2023 |